Dr Sarah Charnaud is a molecular biologist with expertise in parasite survival within host cells. Within ACREME her research focuses on human genetic differences that affect the safety and efficacy of anti-malarial treatments, and to utilize parasite genetics to understand whether treatments have killed the liver stage parasites. She holds a Senior Research Officer post at Walter and Eliza hall Institute, Melbourne, Australia, where she leads the molecular team to understand parasite dynamics within the human host and the genetic diversity and evolutionary history of parasites, and host genetic adaptations to malaria.
